Zevra Therapeutics, Inc. (ZVRA)

8.33 -0.06 (-0.72%) USD  |  NASDAQ  |  Dec 12, 16:00
8.25 -0.08 (-0.96%) Pre-Market: 20:00
More

Zevra Therapeutics EPS Diluted (TTM): 0.6308 for Sept. 30, 2025

EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for ZVRA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Nektar Therapeutics -4.559
XOMA Royalty Corp. 0.7455
Akebia Therapeutics, Inc. -0.0761
NovaBay Pharmaceuticals, Inc. 0.5953
Palatin Technologies, Inc. -4.241